Consensus Genpact Limited Börse Stuttgart

Stocks

35G

BMG3922B1072

Business Support Services

Market Closed - Börse Stuttgart 15:56:14 2026-09-21 EDT			5-day change	1st Jan Change
29.66 ^EUR	-0.07%		-1.98%	-26.22%

09-16	Genpact Insider Sold Shares Worth $367,900, According to a Recent SEC Filing	MT
09-08	Genpact Announces CFO Changes	CI

6a1835e3e1e15c997e427c5.9tAIwDMTsvlXaZ0nI6gOJKYQo-LtXbeVN09rNyQmQtk.m6dH819w9L8YXMtRee9lXNddyr2AF_T4UQIEfU5cNqy4umPxHmbUihUq3A~10810a32c74e0ee7891087c5410a60ff

Analysts' recommendations: Genpact Limited

08-07	Analyst recommendations: Micron Technology, Lockheed Martin, Airbnb, Johnson Controls International, The Allstate Corporation…
05-11	Mizuho Securities Adjusts Genpact Price Target to $39 From $49, Maintains Neutral Rating	MT
12-12	Susquehanna Initiates Genpact With Neutral Rating, $50 Price Target	MT
25-08-07	Genpact Q2 revenue, adjusted profit beats estimates	RE
25-06-27	TD Cowen Raises Price Target on Genpact to $55 From $53, Maintains Buy Rating	MT
25-02-10	Analyst recommendations: Drax, AstraZeneca, HSBC, Broadcom, Tesla...
25-02-10	Analyst recommendations: Aspen, Amazon, Mattel, Broadcom, Tesla…
25-02-07	Deutsche Bank Adjusts Genpact Price Target to $55 From $48, Maintains Hold Rating	MT
25-02-07	TD Cowen Upgrades Genpact to Buy From Hold, Adjusts Price Target to $60 From $45	MT
25-01-21	Jefferies Upgrades Genpact to Buy From Hold, Adjusts Price Target to $55 From $44	MT
25-01-21	Analyst recommendations: Apple, On Holding, Amazon, Palo Alto Networks, Tesla...
24-11-11	Deutsche Bank Adjusts Genpact Price Target to $48 From $37, Maintains Hold Rating	MT
24-11-11	Analyst recommendations: Moderna, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Arista Networks...
24-07-17	JPMorgan Upgrades Genpact to Neutral From Underweight, Price Target is $40	MT
24-07-17	Analyst recommendations: American Airlines, Chevron, UnitedHealth, Bank of America, Eli Lilly...
24-01-30	Mizuho Securities Initiates Genpact With Neutral Rating, Price Target is $40	MT
24-01-17	Citigroup Adjusts Price Target on Genpact to $36 From $35, Maintains Neutral Rating	MT
23-12-15	Baird Downgrades Genpact to Neutral From Outperform, Price Target is $38	MT
23-11-13	Wedbush Lowers Genpact's PT to $35 From $45 After Weaker-Than-Expected Q3 Results, Resets Full-Year 2023 Guidance; Keeps Neutral Rating	MT
23-08-22	JPMorgan Downgrades Genpact to Underweight From Neutral, Price Target is $40	MT
23-08-11	Needham Adjusts Genpact Price Target to $50 From $56, Maintains Buy Rating	MT
23-08-10	Deutsche Bank Adjusts Genpact Price Target to $37 From $48, Maintains Hold Rating	MT
23-08-10	BMO Capital Adjusts Price Target on Genpact to $41 From $46, Maintains Market Perform Rating	MT
23-07-18	Citigroup Downgrades Genpact to Neutral From Buy, Adjusts Price Target to $42 From $46	MT
23-05-11	JPMorgan Cuts Genpact's Price Target to $46 From $53, Neutral Rating Kept	MT

More recommendations

Other Business Support Services

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
GENPACT LIMITED	-	-	-	-
CINTAS CORPORATION				+9.45%
JACOBS SOLUTIONS INC.				+13.34%
BUREAU VERITAS SA				+19.17%
INTERTEK GROUP PLC				+0.55%
ALS LIMITED				+13.63%
ISS A/S				+12.5%
GENPACT LIMITED				+23.56%
EXLSERVICE HOLDINGS, INC.				+26.96%
Average				+14.89%
Weighted average by Cap.				+11.62%